Haoxi Health Technology (HAO): Customer relationships and what they tell investors

Haoxi Health Technology operates as an online marketing and health-technology platform that monetizes by selling digital advertising and marketing services through its subsidiary Beijing Haoxi Digital Technology alongside health‑tech offerings that leverage AI and analytics. For investors evaluating customer exposure, Haoxi’s commercial model is service‑driven, contract‑oriented and concentrated, with revenue generated from discrete advertising campaigns and framework agreements sold to agencies and their clients. Learn more about coverage and relationship signals at https://nullexposure.com/.

Executive snapshot: how Haoxi makes money and where risk lives

Haoxi presents as a small-cap, China‑headquartered marketing provider listed in the U.S. with TTM revenue of roughly USD 42.7 million and thin gross profitability (gross profit TTM USD 2.04 million). The company reported negative operating margin (‑16.8%) and negative EBITDA, signaling ongoing cost pressure despite positive revenue growth year‑over‑year. Institutional ownership is low (about 7.4% of shares), and insiders retain under 1%—a capital structure consistent with high owner fragmentation and limited institutional support.

• Business model drivers: project and framework advertising contracts executed via Beijing Haoxi, digital media planning and recharge services sold to agencies and channel partners.
• Financial posture: revenue generation is intact but profitability is immature, implying upside requires scale or margin improvement rather than simple top‑line growth.
• Market positioning: listed in the Communications Services sector but classified under Advertising Agencies—Haoxi straddles ad tech and health‑tech narratives, which creates both diversification potential and message complexity for the market.

Customer relationships in focus

Below is every customer relationship that surfaced in the available customer review. Each item includes a plain‑English summary and a concise source note.

Tengyuan Media Advertising Co., Ltd.

Beijing Haoxi Digital Technology, a wholly owned subsidiary of Haoxi, was awarded a Recharge Service Framework Contract with a budget of RMB 30 million to provide comprehensive digital advertising services for Tengyuan and its clients, establishing a multi‑campaign commercial arrangement. According to a MarketScreener news report dated May 3, 2026, the contract is positioned as a framework engagement intended to cover recurring ad‑buy and digital service deliveries across Tengyuan’s client roster. (MarketScreener, May 3, 2026)

What the disclosed relationship implies for revenue concentration and contracting

The public record for Haoxi’s customer base is sparse—only the Tengyuan framework contract surfaced in the reviewed materials. From that disclosure and the company’s commercial description, investors should treat the following company‑level signals as central to underwriting risk and upside:

• Contracting posture: framework and project work. Haoxi sells structured framework agreements (the Tengyuan engagement is explicitly labeled a framework contract), indicating the company pursues multi‑period arrangements that provide predictable, contract‑level budgets rather than purely transactional spot buys.
• Revenue concentration risk. The limited set of publicly disclosed customers suggests potential customer concentration, particularly if a handful of agency relationships drive a meaningful share of revenue. That concentration elevates downside if agency budgets compress.
• Commercial criticality and dependency. Advertising services are important to client marketing operations but are inherently cyclical and tied to media spend cycles; framework agreements reduce churn risk but do not eliminate sensitivity to macro ad spend.
• Maturity and scale constraints. With small market capitalization and negative EBITDA, Haoxi requires either scale expansion or margin improvement to convert revenue into sustainable profitability; large framework contracts can accelerate scale but also increase operational delivery demands.

These signals are company‑level inferences drawn from the available disclosures and financial profile rather than covenants or regulatory constraints.

Risks to watch — and where upside can come from

Investors and operators should weigh the following factors when assessing HAO’s customer exposures:

• Concentration and discoverability risk: Publicly disclosed customer relationships are limited, which creates uncertainty about the full revenue base; a single large framework contract can materially move results.
• Operational delivery risk: Framework contracts require consistent delivery across campaigns; the company’s negative operating margin points to execution costs that must be controlled if contracts are to be profitable.
• Revenue cyclicality: Advertising budgets contract in downturns; a company focused on media services will see top‑line variability tied to broader ad spend trends.
• Low institutional ownership: With institutions holding roughly 7.4% of shares, liquidity and analyst coverage are likely limited, which can exaggerate price moves on news about customer wins or losses.

Upside drivers are straightforward: securing additional framework agreements, extending contract tenure with existing agency partners, and improving gross margins through scale or better media economics will convert current revenue momentum into durable earnings improvement.

For a deeper look at relationship analytics and how these customer contracts translate into cash flow projections, visit https://nullexposure.com/.

Bottom line for investors and operators

Haoxi is a service‑centric, advertising‑revenue business that currently operates with small scale and negative operating earnings, making each framework contract both more valuable and more operationally demanding. The RMB 30 million framework with Tengyuan is the only publicly disclosed customer relationship in the reviewed materials and therefore merits elevated attention for revenue forecasting. Investors should treat disclosed contracts as directional indicators rather than a complete map of customer exposure, and operators should prioritize contract fulfillment efficiency and diversification of agency partners to reduce concentration risk.

If your evaluation requires drilling into customer tenure, contract cadence, or the revenue split across media vs. health technology initiatives, our platform centralizes relationship evidence and business signals for decision support: https://nullexposure.com/.